PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F0KS9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $35,623
Award facts
- Contract value 100% obligated
- $35,623.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $35,623.20 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of pharmaceutical products and medical supplies to federal customers, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company serves critical medical procurement needs for military and veteran healthcare systems through the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The parent SPE2DX contract demonstrates AmerisourceBergen Drug Corp's significant capability and capacity in the federal medical supply market, positioning the company as a key vendor within the DLA's Pharmaceutical Prime Vendor Global Program framework.
Quick answers
Who was awarded contract SPE2D825F0KS9?
SPE2D825F0KS9 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2D825F0KS9 worth?
The government has obligated $35,623 on SPE2D825F0KS9.
Is contract SPE2D825F0KS9 an order under another contract?
Yes. SPE2D825F0KS9 is a delivery order under SPE2DX22D0030, an indefinite delivery contract.
Was contract SPE2D825F0KS9 competed?
The extent of competition for SPE2D825F0KS9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award